journal article·2021-06-30Open access

Periodic Mesoporous Ionosilica Nanoparticles for Green Light Photodynamic Therapy and Photochemical Internalization of siRNA

Braham Mezghrani, Lamiaa M. A. Ali, Sébastien Richeter, Jean-Olivier Durand, Peter Hesemann, Nadir Bettache

ACS Applied Materials & Interfaces· Volume 13· Issue 25

Abstract

We report periodic mesoporous ionosilica nanoparticles (PMINPs) as versatile nano-objects for imaging, photodynamic therapy (PDT), and efficient adsorption and delivery of small interfering RNA (siRNA) into breast cancer cells. In order to endow these nanoparticles with PDT and siRNA photochemical internalization (PCI) properties, a porphyrin derivative was integrated into the ionosilica framework. For this purpose, we synthesized PMINPs via hydrolysis-cocondensation procedures from oligosilylated ammonium and porphyrin precursors. The formation of these nano-objects was proved by transmission electron microscopy. The formed nanoparticles were then thoroughly characterized via solid-state NMR, nitrogen sorption, dynamic light scattering, and UV–vis and fluorescence spectroscopies. Our results indicate the formation of highly porous nanorods with a length of 108 ± 9 nm and a width of 54 ± 4 nm. A significant PDT effect of type I mechanism (95 ± 2.8% of cell death) was observed upon green light irradiation in nanoparticle-treated breast cancer cells, while the blue light irradiation caused a significant phototoxic effect in non-treated cells. Furthermore, PMINPs formed stable complexes with siRNA (up to 24 h), which were efficiently internalized into the cells after 4 h of incubation mostly with the energy-dependent endocytosis process. The PCI effect was obvious with green light irradiation and successfully led to 83 ± 1.1% silencing of the luciferase gene in luciferase-expressing breast cancer cells, while no gene silencing effect was observed with blue light irradiation. The present work highlights the high potential of porphyrin-doped PMINPs as multifunctional nanocarriers for nucleic acids, such as siRNA, with a triple ability to perform imaging, PDT, and PCI.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

IBMM, Univ. Montpellier, CNRS, ENSCM; Avenue Charles Flahault, CEDEX 05, 34093 Montpellier, France

ICGM, Univ Montpellier-CNRS-ENSCM, 34090 Montpellier, France

Department of Biochemistry, Medical Research Institute, University of Alexandria, Alexandria 21561, Egypt

Funding

Minist??re de l'Enseignement Sup??rieur et de la Recherche Scientifique · Franco-Algerian steering committe

References (65)

Show source-provided references
1. 10.1002/adma.20150514710.1002/adma.201505147 ↗
2. 10.1016/j.biomaterials.2020.12019110.1016/j.biomaterials.2020.120191 ↗
3. 10.1039/c5nr05649g10.1039/c5nr05649g ↗
4. 10.1002/adfm.20170732510.1002/adfm.201707325 ↗
5. 10.1016/j.biomaterials.2016.03.01910.1016/j.biomaterials.2016.03.019 ↗
6. 10.1016/j.phrs.2020.10474210.1016/j.phrs.2020.104742 ↗
7. 10.1002/adma.20170761210.1002/adma.201707612 ↗
8. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
9. 10.1021/acsnano.7b0822510.1021/acsnano.7b08225 ↗
10. 10.1002/adfm.20190771610.1002/adfm.201907716 ↗
11. 10.1039/c8tb00541a10.1039/c8tb00541a ↗
12. 10.1021/jacs.9b0608610.1021/jacs.9b06086 ↗
13. 10.1021/acsami.8b1680110.1021/acsami.8b16801 ↗
14. 10.1002/cnma.20170026410.1002/cnma.201700264 ↗
15. 10.1039/c6tb00638h10.1039/c6tb00638h ↗
16. 10.1039/d0bm00586j10.1039/d0bm00586j ↗
17. 10.1039/c6tb01915c10.1039/c6tb01915c ↗
18. 10.1039/c9cc05703j10.1039/c9cc05703j ↗
19. 10.1002/adfm.20180023510.1002/adfm.201800235 ↗
20. 10.1021/acs.jpcc.6b0945710.1021/acs.jpcc.6b09457 ↗
21. 10.1021/acsami.7b0726410.1021/acsami.7b07264 ↗
22. 10.1002/cnma.20190020210.1002/cnma.201900202 ↗
23. 10.1021/acsanm.8b0002010.1021/acsanm.8b00020 ↗
24. 10.3390/pharmaceutics1202018310.3390/pharmaceutics12020183 ↗
25. 10.3390/ijms2021549110.3390/ijms20215491 ↗
26. Akki R. A. · J. Drug Delivery Ther. · 2019 · 9 · 688
27. 10.1021/acsnano.8b0515110.1021/acsnano.8b05151 ↗
28. 10.1166/jbn.2019.266310.1166/jbn.2019.2663 ↗
29. 10.4155/tde.13.7810.4155/tde.13.78 ↗
30. Berg K. · Cancer Res. · 1999 · 59 · 1180
31. 10.1039/c1jm10422e10.1039/c1jm10422e ↗
32. 10.1039/b925352a10.1039/b925352a ↗
33. 10.1039/b616421h10.1039/b616421h ↗
34. 10.1021/acsnano.1c0031610.1021/acsnano.1c00316 ↗
35. 10.1016/j.addr.2009.03.00910.1016/j.addr.2009.03.009 ↗
36. 10.1021/cr100440g10.1021/cr100440g ↗
37. Llewellyn P. · 2014 · 52910.1016/B978-0-08-097035-6.00013-9 ↗
38. 10.1142/s108842461950145110.1142/s1088424619501451 ↗
39. 10.2174/187503890090203009910.2174/1875038900902030099 ↗
40. 10.3109/1071576100370980210.3109/10715761003709802 ↗
41. 10.1021/jacs.5b0602510.1021/jacs.5b06025 ↗
42. 10.1021/acs.jpca.6b0361510.1021/acs.jpca.6b03615 ↗
43. 10.1039/c6cs00616g10.1039/c6cs00616g ↗
44. 10.1021/jacs.6b0000710.1021/jacs.6b00007 ↗
45. 10.1021/acsnano.0c0561710.1021/acsnano.0c05617 ↗
46. 10.1088/0957-4484/20/13/13510210.1088/0957-4484/20/13/135102 ↗
47. 10.1002/cnr2.118610.1002/cnr2.1186 ↗
48. 10.1002/adma.20080054810.1002/adma.200800548 ↗
49. 10.1117/1.308342710.1117/1.3083427 ↗
50. 10.1016/j.jphotobiol.2020.11212210.1016/j.jphotobiol.2020.112122 ↗
51. 10.1016/j.taap.2009.08.01010.1016/j.taap.2009.08.010 ↗
52. 10.1016/j.biomaterials.2011.01.03210.1016/j.biomaterials.2011.01.032 ↗
53. 10.7150/thno/v01p024010.7150/thno/v01p0240 ↗
54. 10.1021/jacs.7b0555910.1021/jacs.7b05559 ↗
55. 10.1007/s11671-010-9603-410.1007/s11671-010-9603-4 ↗
56. 10.1007/s11095-005-8175-y10.1007/s11095-005-8175-y ↗
57. 10.1038/mtm.2014.5810.1038/mtm.2014.58 ↗
58. 10.1038/mt.2011.29410.1038/mt.2011.294 ↗
59. 10.1016/j.jconrel.2010.06.00810.1016/j.jconrel.2010.06.008 ↗
60. 10.1039/c6nj01473a10.1039/c6nj01473a ↗
61. 10.1016/j.jcis.2016.07.06910.1016/j.jcis.2016.07.069 ↗
62. 10.1016/j.seppur.2017.07.06710.1016/j.seppur.2017.07.067 ↗
63. 10.1039/c9ra09133e10.1039/c9ra09133e ↗
64. 10.1016/j.jhazmat.2020.12469810.1016/j.jhazmat.2020.124698 ↗
65. 10.1021/acs.bioconjchem.9b0059010.1021/acs.bioconjchem.9b00590 ↗